Format

Send to

Choose Destination
Obstet Gynecol. 2001 May;97(5 Pt 2):816-8.

Breast-feeding by a cyclosporine-treated mother.

Author information

1
Department of Biobehavioral Nursing and Health Systems, School of Nursing, University of Washington, Box 357266, Seattle, WA 98195, USA. binga@u.washington.edu

Abstract

BACKGROUND:

Cyclosporine is known to be excreted in breast milk, but levels in infants are not known. Post-transplant breast-feeding has been contraindicated in mothers treated with calcineurin inhibitors such as cyclosporine.

CASE:

A 35-year-old woman exclusively breast-fed her infant during the first 10.5 months of life while she was being treated with cyclosporine. Cyclosporine measurements in infant and maternal blood and breast milk revealed a mean breast milk/maternal blood level ratio of 84%, but undetectable levels in the infant. The infant grew and developed normally.

CONCLUSION:

The infant of a cyclosporine-treated mother was breast-fed exclusively during the first 10.5 months of life and did not absorb a detectable amount of the drug. Fetal growth and development were normal.

PMID:
11336764
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center